摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-hydroxyphenylamino)-6-chloro-3-nitropyridine | 1229016-71-0

中文名称
——
中文别名
——
英文名称
2-(4-hydroxyphenylamino)-6-chloro-3-nitropyridine
英文别名
2(4-hydroxyphenylamino)-6-chloro-3-nitropyridine;2-(4-Hydroxyphenylamino)-6-chloro-3-nitropyridine;4-[(6-chloro-3-nitropyridin-2-yl)amino]phenol
2-(4-hydroxyphenylamino)-6-chloro-3-nitropyridine化学式
CAS
1229016-71-0
化学式
C11H8ClN3O3
mdl
——
分子量
265.656
InChiKey
YCXRDVZZYPAAOT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    91
  • 氢给体数:
    2
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    2-(4-hydroxyphenylamino)-6-chloro-3-nitropyridine氢气溶剂黄146 、 sodium nitrite 作用下, 以 乙酸乙酯 为溶剂, 生成 4-(5-chloro-3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)phenol
    参考文献:
    名称:
    Hit to lead evaluation of 1,2,3-triazolo[4,5-b]pyridines as PIM kinase inhibitors
    摘要:
    PIM kinases have become targets of interest due to their association with biochemical mechanisms affecting survival, proliferation and cytokine production. 1,2,3-Triazolo[4,5-b]pyridines were identified as PIM inhibitors applying a scaffold hopping approach. Initial exploration around this scaffold and X-ray crystallographic data are hereby described. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.12.130
  • 作为产物:
    描述:
    2,6-二氯-3-硝基吡啶三乙胺对氨基苯酚正己烷乙酸乙酯 作用下, 以 甲醇 为溶剂, 反应 2.0h, 以to afford 640 mg (yield: 78%) of the desired compound的产率得到2-(4-hydroxyphenylamino)-6-chloro-3-nitropyridine
    参考文献:
    名称:
    NOVEL 2,6-SUBSTITUTED-3-NITROPYRIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME
    摘要:
    本发明涉及一种新型的2,6-取代-3-硝基吡啶衍生物化合物,其制备方法以及包括该化合物的药物组合物,用于预防和治疗骨质疏松症。本发明的2,6-取代-3-硝基吡啶衍生物化合物增加成骨细胞活性并有效抑制破骨细胞的分化,因此可用于预防和治疗骨质疏松症。
    公开号:
    US20110306606A1
点击查看最新优质反应信息

文献信息

  • EP2394993
    申请人:——
    公开号:——
    公开(公告)日:——
  • NOVEL 2,6-SUBSTITUTED-3-NITROPYRIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME
    申请人:Ryu Jei Man
    公开号:US20110306606A1
    公开(公告)日:2011-12-15
    The present invention relates to a novel 2,6-substituted-3-nitropyridine derivative compound, a method for preparing the same, and a pharmaceutical composition including the same for prevention and treatment of osteoporosis. The 2,6-substituted-3-nitropyridine derivative compound of the present invention increases osteoblast activity and effectively inhibits the differentiation of osteoclasts, and thus can be usefully used for the prevention and treatment of osteoporosis.
    本发明涉及一种新型的2,6-取代-3-硝基吡啶衍生物化合物,一种制备该化合物的方法,以及包括该化合物的用于预防和治疗骨质疏松症的药物组合物。本发明的2,6-取代-3-硝基吡啶衍生物化合物增加成骨细胞活性并有效抑制破骨细胞的分化,因此可用于预防和治疗骨质疏松症。
  • Hit to lead evaluation of 1,2,3-triazolo[4,5-b]pyridines as PIM kinase inhibitors
    作者:Joaquín Pastor、Julen Oyarzabal、Gustavo Saluste、Rosa María Alvarez、Virginia Rivero、Francisco Ramos、Elena Cendón、Carmen Blanco-Aparicio、Nuria Ajenjo、Antonio Cebriá、M.I. Albarrán、David Cebrián、Ana Corrionero、Jesús Fominaya、Guillermo Montoya、Marco Mazzorana
    DOI:10.1016/j.bmcl.2011.12.130
    日期:2012.2
    PIM kinases have become targets of interest due to their association with biochemical mechanisms affecting survival, proliferation and cytokine production. 1,2,3-Triazolo[4,5-b]pyridines were identified as PIM inhibitors applying a scaffold hopping approach. Initial exploration around this scaffold and X-ray crystallographic data are hereby described. (C) 2012 Elsevier Ltd. All rights reserved.
查看更多